Publicly, most chief executives are begrudgingly positive about the Sarbanes-Oxley Act. In private, some of those same CEOs express grave reservations about its costs and complexity. If they are self-contradictory, it's because few want to risk being cast as spokespersons against good corporate governance.
Industry front groups have been more open in their criticism of Sarbanes-Oxley, citing it as a threat to U.S. competitiveness. The naysayers have warned that the high cost of compliance will squeeze profit margins, discouraging initial public offerings (IPO) and forcing smaller public companies to delist.
See full Article.
Posts
